CALLUNA PHARMA AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−16,0 mill kr).
CALLUNA PHARMA AS is registered as a limited company in Oslo, Oslo with organisation number 932255189. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2023 and has 10 registered employees. Registered share capital is NOK 1.0m, divided into 104166995 shares. The company's stated purpose is: “Å investere i farmasøytiske selskaper og virksomheter, herunder å realisere slike investeringer, samt all annen virksomhet knyttet til dette.”. The most recent filed accounts, for the 2025 financial year, show NOK 36.3m in revenue and NOK −16.0m in operating profit.
Former names: NFH 230952 AS
Key figures · 2025
Financial health · 2025
Who owns CALLUNA PHARMA AS?
CALLUNA PHARMA AS has 5 registered shareholders:
- CALLUNA PHARMA POOLCO AS 35.9%
- FORBION VENTURES FUND VI COOPERATIV 24.1%
- FORCAL I INVESTMENT FUND 19.9%
- FORBION CAPITAL FUND IV COOPERATIEF 16.7%
- STITCHING ADMINISTRATIEKANTOOR OXIT 3.3%
Which companies does CALLUNA PHARMA AS own?
CALLUNA PHARMA AS holds a stake in 1 company:
- ARXX THERAPEUTICS AS 100.0%
Frequently asked questions about CALLUNA PHARMA AS
Who owns CALLUNA PHARMA AS?
CALLUNA PHARMA POOLCO AS is the largest registered owner, with 35.9%.
What is the revenue of CALLUNA PHARMA AS?
CALLUNA PHARMA AS had revenue of NOK 36.3m in 2025.
Who is the general manager of CALLUNA PHARMA AS?
Mark William-Semrau Gaffney is registered as general manager of CALLUNA PHARMA AS.
Where is CALLUNA PHARMA AS based?
CALLUNA PHARMA AS has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.